Literature DB >> 17561268

The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy.

Shigeru Saito1, Saito Shigeru, Akitoshi Nakashima, Nakashima Akitoshi, Subaru Myojo-Higuma, Myojo-Higuma Subaru, Arihiro Shiozaki.   

Abstract

NK cells kill tumor cells and virus-infected cells as well as secrete a variety of cytokines. These effector functions are regulated by the balance between activating receptor signals and inhibitory receptor signals which are triggered by specific major histocompatibility complex (MHC) or non-MHC ligands. It is thought currently that the balance between immunostimulation and immunoregulation in T cell immunity is achieved by a Th1/Th2/Th3/Tr1 and CD4(+)CD25(+) regulatory T (Treg) cell paradigm. Here, we discuss the cytokine paradigm of NK cells in human pregnancy. During normal, intact pregnancy, peripheral blood NKr1 cells and decidual NK3 cells increase, while these NK cell populations decrease significantly in miscarriage cases, suggesting that an imbalance in NK1/NK2/NK3/NKr1 is correlated with miscarriage. Recent investigations have shown that not only Treg cells, but also regulatory NK (NK reg) cells, play very important roles in the maintenance of pregnancy. We summarize the progress in studying NK reg cells and focus on how NK reg cells and cytotoxic NK cells affect the reproductive immune response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561268     DOI: 10.1016/j.jri.2007.04.007

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  38 in total

1.  HLA-F is a surface marker on activated lymphocytes.

Authors:  Ni Lee; Akiko Ishitani; Daniel E Geraghty
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

2.  The effect of kisspeptin on the functional characteristics of isolated NK cells.

Authors:  S V Shirshev; I V Nekrasova; O L Gorbunova; E G Orlova; I L Maslennikova
Journal:  Dokl Biol Sci       Date:  2015-11-04

Review 3.  CD56bright natural killer (NK) cells: an important NK cell subset.

Authors:  Aurélie Poli; Tatiana Michel; Maud Thérésine; Emmanuel Andrès; François Hentges; Jacques Zimmer
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

4.  Association of peripheral NK cell counts with Helios+ IFN-γ- Tregs in patients with good long-term renal allograft function.

Authors:  K Trojan; L Zhu; M Aly; R Weimer; N Bulut; C Morath; G Opelz; V Daniel
Journal:  Clin Exp Immunol       Date:  2017-03-13       Impact factor: 4.330

Review 5.  The liver works as a school to educate regulatory immune cells.

Authors:  Fenglei Li; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

6.  Multiple KIR gene polymorphisms are associated with plasma viral loads in SIV-infected rhesus macaques.

Authors:  Porntip Chaichompoo; Pavel Bostik; Susan Stephenson; Suthiphol Udompunturuk; Jaruda Kobkitjaroen; Kovit Pattanapanyasat; Aftab A Ansari
Journal:  Cell Immunol       Date:  2010-04-01       Impact factor: 4.868

7.  CD56(bright)CD25+ NK cells are preferentially recruited to the maternal/fetal interface in early human pregnancy.

Authors:  Yu Tao; Yan-Hong Li; Hai-Lan Piao; Wen-Jie Zhou; Di Zhang; Qiang Fu; Song-Cun Wang; Da-Jin Li; Mei-Rong Du
Journal:  Cell Mol Immunol       Date:  2014-05-05       Impact factor: 11.530

8.  Oxidative stress induces p38MAPK-dependent senescence in the feto-maternal interface cells.

Authors:  Jin Jin; Lauren Richardson; Samantha Sheller-Miller; Nanbert Zhong; Ramkumar Menon
Journal:  Placenta       Date:  2018-05-17       Impact factor: 3.481

9.  Suppression of natural killer cell cytotoxicity in postpartum women.

Authors:  Maureen Groer; Nagwa El-Badri; Julie Djeu; Monalisa Harrington; Jeanne Van Eepoel
Journal:  Am J Reprod Immunol       Date:  2010-01-05       Impact factor: 3.886

Review 10.  Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.

Authors:  Shernan G Holtan; Douglas J Creedon; Paul Haluska; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.